Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

Healthcare Biotechnology
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc. (MGNX)

Accesswire August 7, 2024

Class Action Announcement for MacroGenics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against MacroGenics, Inc

Newsfile August 7, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire August 7, 2024

MGNX DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline

Accesswire August 7, 2024

Shareholders that lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX

Accesswire August 6, 2024

Investors who lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class Action - MGNX

Accesswire August 6, 2024

ROSEN, SKILLED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX

Newsfile August 6, 2024

MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire August 6, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire August 6, 2024

MGNX Investors Have Opportunity To Lead MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire August 6, 2024

MacroGenics (MGNX) Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo - Hagens Berman

Accesswire August 6, 2024

MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MGNX

Accesswire August 6, 2024

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire August 6, 2024

Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

PR Newswire August 6, 2024

MacroGenics, Inc. (MGNX) Investors: September 24, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Accesswire August 5, 2024

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX

Newsfile August 5, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Newsfile August 5, 2024

MacroGenics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX

Accesswire August 5, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Accesswire August 5, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX

Newsfile August 5, 2024